PCAS — Regulatory Filings 2016

Apr 27, 2016

PCAS: CORPORATE NAME CHANGE

Longjumeau, April 27th , 2016

After changing its logo and launching a new website (www.pcas.com), the Extraordinary Shareholder's Meeting of the company Produits Chimiques et Auxiliaires de Synthèse has decided to change its corporate name to PCAS.

About PCAS (Euronext Paris: PCA, eligible for the PEA-PME plan)

PCAS specialises in the development and production of complex molecules for Life Sciences and Innovative Technologies. With 7% of its turnover dedicated to R&D and a wide international presence, PCAS is the preferred industrial partner of market-leading major global groups. The company offers a growing range of proprietary products and solutions in leading-edge segments, and also includes two subsidiaries with very strong potential: Protéus in biotechnology and Enersens in high-performance insulation. With a particularly high standard of performance, PCAS achieved net sales of €179.1 million in 2015 and employs nearly 900 people in six countries.

For more information about PCAS: www.pcas.com

Vincent Touraille / Eric Moissenot PCAS

Tel.: +33 1 69 79 61 32 www.pcas.com

PCAS NewCap

Emmanuel Huynh / Louis-Victor Delouvrier NewCap Financial Communication & investors relations

Tel.: +33 1 44 71 94 94 pcas@newcap.eu